Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +919925223434 (International callers) or +919925223434 (Indian callers).
Yes, typically. In Third Party, White Label, Loan Licence and Private Label arrangements, the marketing company usually needs a Wholesale Drug License (Form 20B and/or Form 21B) if it purchases, stocks, and invoices the finished product under its own brand — separate from the manufacturer's own manufacturing license (Form 25/28).
Yes — this is standard practice in Third Party and White Label Manufacturing, where a single GMP facility produces for several client brands under separate agreements.
Timelines vary by state and product category, but typically range from a few weeks to a few months, depending on document readiness and inspection scheduling.
Form 51 is required whenever a product is being marketed under a brand or trade name, which applies to virtually all branded pharmaceutical launches.
No. In Third Party, White Label, and Private Label models, the manufacturer holds the license and manufacturing responsibility. A Loan License is the exception — there, the applicant holds their own license for the borrowed facility.
Have a different query?
Please feel free to contact us by submitting a business inquiry.
Chat with us
Chat with us
